Dr. Dragovich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1301 Palm Ave Ste 600
Jacksonville, FL 32207Phone+1 904-202-7300Fax+1 904-202-7433
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1997 - 2000
- Louis A Weiss Memorial HospitalResidency, Internal Medicine, 1994 - 1997
- University of Belgrade Faculty of MedicineClass of 1988
Certifications & Licensure
- AZ State Medical License 2000 - 2026
- FL State Medical License 2024 - 2026
- IL State Medical License 1997 - 2002
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2002 Jun 01
- PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma Start of enrollment: 2005 Dec 01
- S9304A Study of Protein Expression in Tumor Tissue Samples From Patients With Stage II or Stage III Rectal Cancer Enrolled in Clinical Trial SWOG-9304 Start of enrollment: 2009 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 66 citationsA phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumorsDaruka Mahadevan, Ruth Plummer, M. Squires, D. M. Rensvold, Sandy Kurtin
Annals of Oncology. 2011-09-01 - 136 citationsStability of Phosphoprotein as a Biological Marker of Tumor SignalingAmanda F. Baker, Tomislav Dragovich, Nathan T. Ihle, Ryan Williams, Cecilia M. Fenoglio-Preiser
Clinical Cancer Research. 2005-06-15 - 19 citationsManagement strategies in pancreatic cancer.Christopher J Campen, Tomislav Dragovich, Amanda F. Baker
American Journal of Health-System Pharmacy. 2011-04-01
Press Mentions
- Banner MD Anderson Launches Landmark Research ExpansionFebruary 11th, 2022
Grant Support
- Clinical Trials CoreNational Cancer Institute2007–2011
- Treatment Of Hypoxia Resistance In Pancreatic Cancer - ClinicalNational Cancer Institute2005–2009
- Core -- Clinical ResourcesNational Cancer Institute2002
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: